Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1952 Apr;135(4):454–469. doi: 10.1097/00000658-195204000-00003

The Response of Dicumarol-induced Hypoprothrombinemia to Vitamin K1*

Alfredo Rehbein, Alfred Jaretzki III, David V Habif
PMCID: PMC1802488  PMID: 14915438

Full text

PDF
454

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BATTLE W. D., CAPPS R. T. The effects of 4 hydroxycoumarin anticoagulant No. 63 upon the prothrombin time in dogs and human beings. J Lab Clin Med. 1950 Jan;35(1):8–15. [PubMed] [Google Scholar]
  2. BLAUSTEIN A. U., CROCE J. J., Jr, ALBERIAN M., RICHEY N. Preliminary report on the clinical use of a new anticoagulant, phenylindandione. Circulation. 1950 May;1(5):1195–1204. doi: 10.1161/01.cir.1.5.1195. [DOI] [PubMed] [Google Scholar]
  3. BURKE G. E., WRIGHT I. S. Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties. Circulation. 1951 Feb;3(2):164–170. doi: 10.1161/01.cir.3.2.164. [DOI] [PubMed] [Google Scholar]
  4. BURT C. C., WRIGHT H. P., KUBIK M. Clinical tests of a new coumarin substance; a report to the Medical Research Council. Br Med J. 1949 Dec 3;2(4639):1250–1254. doi: 10.1136/bmj.2.4639.1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BUTLER J. J., JAMES D. F. Major bleeding resulting from a single dose of dicumarol. Ann Intern Med. 1950 Apr;32(4):731–735. doi: 10.7326/0003-4819-32-4-731. [DOI] [PubMed] [Google Scholar]
  6. Fieser L. F. THE SYNTHESIS OF VITAMIN K1. Science. 1940 Jan 12;91(2350):31–36. doi: 10.1126/science.91.2350.31. [DOI] [PubMed] [Google Scholar]
  7. JAQUES L. B., GORDON E LEPP E. A new prothrombopenic drug, phenylindanedione. Can Med Assoc J. 1950 May;62(5):465–470. [PMC free article] [PubMed] [Google Scholar]
  8. MILLER R., HARVEY W. P., FINCH C. A. Antagonism of dicumarol by vitamin K preparations. N Engl J Med. 1950 Feb 9;242(6):211–215. doi: 10.1056/NEJM195002092420604. [DOI] [PubMed] [Google Scholar]
  9. OVERMAN R. S., SORENSON C. W., WRIGHT I. S. Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia. J Am Med Assoc. 1951 Feb 10;145(6):393–399. doi: 10.1001/jama.1951.02920240029008. [DOI] [PubMed] [Google Scholar]
  10. SHAPIRO S., WEINER M., SIMSON G. The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia. N Engl J Med. 1950 Nov 16;243(20):775–779. doi: 10.1056/NEJM195011162432004. [DOI] [PubMed] [Google Scholar]
  11. SHOSHKES M., GEYER R. P., YEE G. S., STARE F. J. The treatment of dicumarol-induced hypoprothrombinemia in dogs with emulsified vitamin K1 administered intravenously. J Lab Clin Med. 1950 Oct;36(4):531–536. [PubMed] [Google Scholar]
  12. WATKIN D. M., VAN ITALLIE T. B., LOGAN W. B., GEYER R. P., DAVIDSON C. S., STARE F. J. The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously. J Lab Clin Med. 1951 Feb;37(2):269–271. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES